Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06152627Recruiting
Voice Therapy for Muscle Tension Dysphonia
This study tests a new way of doing voice therapy for people with muscle tension dysphonia — a condition where the muscles around the voice box are too tight, making it hard to speak clearly. The goal is to see if this structured approach helps improve voice function.
Atlanta, GeorgiaAges 14 years+ - NCT06129734RecruitingPhase 1/Phase 2
Maintenance therapy after stem cell transplant for blood cancers
This study tests whether giving two drugs, decitabine and venetoclax, after a stem cell transplant can help keep your blood cancer from coming back. It is for people with acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), or MDS/AML who have had or will have a stem cell transplant.
Cleveland, OhioAges 18 years+ - NCT06136767Recruiting
Registry for systemic eczema treatments
This study is a registry for people with eczema (atopic dermatitis) who are under 26 and have taken or plan to take body-wide treatments like pills or injections. By joining, you help researchers track how these treatments work over time.
Baltimore, MarylandAges 1–26 - NCT06134960RecruitingPhase 1
KD-496 CAR T-cells for advanced solid tumors with NKG2DL or CLDN18.2
This trial tests a new type of immune cell therapy called KD-496, which is a CAR T-cell designed to attack tumors that have NKG2DL or CLDN18.2 markers. It may be an option for people with advanced solid tumors (commonly stomach or pancreatic cancer) who have tried at least two prior treatments.
Beijing, Beijing MunicipalityAges 18–75 - NCT06141369Recruiting
Personalized mRNA vaccine for advanced endocrine tumors
This trial tests a personalized mRNA vaccine made from your tumor's genetic information. It is for people with advanced endocrine tumors who have no standard treatment options left, and aims to help the immune system fight the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06152328Recruiting
Virtual reality mirror therapy for arm recovery after stroke
This study tests whether virtual reality mirror therapy can help people recover arm movement after a stroke. It is for people who had an ischemic stroke a few months ago and still have some arm weakness.
Bolu, MerkezAges 40–80 - NCT06148311Enrolling by invitationPhase 2
Dexmedetomidine film for autonomic crises in Familial Dysautonomia
This study tests a new dissolvable film containing dexmedetomidine (a medicine that calms overactive stress responses) for people with Familial Dysautonomia who experience sudden episodes called autonomic crises. It aims to treat these crises at home without needing a hospital visit.
New York, New YorkAges 16–80 - NCT03891160Recruiting
Using heart scans to plan a support pump in children
This trial is testing a way to help doctors assess babies and children with congenital heart disease and heart failure before placing a temporary heart support pump. It may help improve planning by using heart scans to decide who needs support and how to prepare.
Gainesville, FloridaAges Any age - NCT05931393RecruitingPhase 2
Cabozantinib retreatment after it helped, in kidney cancer study
This Phase 2 study tests a “next-step” cabozantinib strategy for advanced kidney cancer (RCC) after your cancer previously responded to cabozantinib and then progressed. It aims to see if re-using cabozantinib in a planned sequence can control the cancer again with manageable side effects.
Dallas, TexasAges 18 years+ - NCT06006637Recruiting
Measuring and reducing autism symptoms
This study tests a new platform designed to measure and reduce autism symptoms in children ages 2 to 8. It may help if your child has an autism diagnosis and is not taking psychiatric medications.
New York, New YorkAges 2–8 - NCT03517579Recruiting
Personalized treatment for Graves and certain thyroid cancers
This trial tests a personalized approach to treat thyroid disorders, either Graves’ disease or certain thyroid cancers that may need radioactive iodine treatment. It may help by matching treatment to your specific test results and needs.
Baltimore, MarylandAges 21–65 - NCT06124157RecruitingPhase 2
Targeted therapy plus chemo for children with Ph+ or Ph-like B-ALL
This trial tests if adding a targeted drug (dasatinib or imatinib) to a chemotherapy combination with blinatumomab works better for children and young adults with a specific genetic form of B-cell acute lymphoblastic leukemia. The goal is to see if this approach can improve treatment outcomes for patients with Philadelphia chromosome-positive or ABL-class Ph-like B-ALL.
Birmingham, AlabamaAges 1 year–46 years - NCT06122831RecruitingPhase 1/Phase 2
TQ05105 and TQB3617 for myelofibrosis
This trial tests a combination of two oral medications for people with myelofibrosis, a type of bone marrow cancer. It may be an option if you have not been helped by standard JAK inhibitor therapy or if you have never tried one.
Guangzhou, GuangdongAges 18 years+ - NCT06113068Recruiting
Fistura procedure for complex anal fistulas
This trial tests a new procedure called Fistura to treat complex anal fistulas (abnormal tunnels between the anal canal and skin). It uses radiofrequency energy to close the fistula while preserving muscle. The study is for people whose fistula has already been drained with a temporary seton stitch.
Braine-l'AlleudAges 18 years+ - NCT06122389RecruitingPhase 3
Study of SHR2554 for T-cell lymphoma
This trial tests a new drug called SHR2554 (compared to chidamide) for T-cell lymphoma that has not responded to or come back after prior treatment. It's a Phase 3 study to see if the drug can help control the cancer.
Beijing, Beijing MunicipalityAges 18–70 - NCT06128447RecruitingPhase 3
New chewable drug for hookworm, roundworm and whipworm
This trial tests a new chewable tablet (ZP5-9676) to treat common intestinal worm infections. It compares the new drug to a placebo (fake pill) to see if it's safe and effective.
AmericaninhaAges 6 months–59 years - NCT06129175RecruitingPhase 2/Phase 3
Stem cells for recent moderate to severe stroke
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
Cheras, Kuala LumpurAges 18 years+ - NCT06010719RecruitingPhase 4
Azithromycin for severe malnutrition in children
This study tests whether adding the antibiotic azithromycin to standard nutritional care helps young children with severe acute malnutrition recover better. It is for children aged 6 to 59 months in Burkina Faso who have uncomplicated malnutrition and are not currently on antibiotics.
Nouna, KossiAges 6 months–4.9 years - NCT06128746Recruiting
Magnetic brain stimulation for arm stiffness in children with hemiplegia
This trial tests whether a magnetic stimulation treatment (called rTMS) can help reduce muscle stiffness in children with hemiplegia caused by a brain injury. The treatment is non-invasive and may improve arm movement.
Hong Kong, Hong KongAges 4–18 - NCT06124768Recruiting
Comparing two blood clot removal methods for leg clots
This trial compares two ways of doing a mechanical blood clot removal procedure for people with a new deep vein thrombosis (a blood clot in a deep vein, often in the leg). The goal is to see which method works better.
Shanghai, Shanghai MunicipalityAges 18–85 - NCT06111729Recruiting
Wristband to help stop nail biting
This study tests a special device that helps you become more aware of when you bite your nails, so you can stop. It may help if you have chronic nail biting and want to break the habit.
New York, New YorkAges 18–95 - NCT06128681Recruiting
Diagnosis and treatment of mediastinal problems
This study tests a comprehensive approach to diagnosing and treating problems in the mediastinum (the space between your lungs). It uses a bronchoscopy (a camera through the airway) to take a biopsy and possibly treat the area, all while you are under general anesthesia.
TianjinAges 18–80 - NCT06108089Recruiting
Hypoxia imaging for head and neck cancer treatment planning
This study uses a special MRI scan to measure oxygen levels in your head and neck tumor. The goal is to learn if this scan can help doctors choose the best treatment plan for you.
Salt Lake City, UtahAges 18 years+ - NCT06112522RecruitingPhase 2
Tirbanubulin for superficial basal cell carcinoma
This trial tests the safety and effectiveness of tirbanubulin gel to treat a type of skin cancer called superficial basal cell carcinoma (sBCC). It is for people who have not been treated for this cancer before and have a small spot (less than 1.5 cm) that is not on the face or scalp.
Nice, Alpes-maritimesAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.